Emily Baumrin, MD, MSCE

faculty photo
Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
Director, Graft-versus-host Disease Subspecialty Clinic, Department of Dermatology, University of Pennsylvania
Full Member (research) in Hematologic Malignancies, Abramson Cancer Center, University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Department: Dermatology

Contact information
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine, South Tower, Suite 729
Philadelphia, PA 19104
Office: (215)-614-0700
Education:
BA (Biochemistry)
Dartmouth College, 2010.
MD (Medicine)
University of Pennsylvania, Perelman School of Medicine, 2015.
MSCE (Epidemiology)
University of Pennsylvania, 2023.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

GVHD, oncodermatology, complex medical dermatology

Description of Research Expertise

Epidemiology, Psychometric methods, Outcome development, Qualitative methods , Cohort Studies

Selected Publications

Lazarow H, Carulli A, McWilliams T, Kucharczuk C, Hollander L, Catania C, Munshi P, Gabriel P, Loren A, Porter D, Baumrin E.: Vitamin C deficiency in allogeneic hematopoietic cell transplantation recipients in the peri-transplant period. Support Care Cancer 33: 755, Aug 2025.

Baumrin E, Pidala J, Mitchell S, Onstad L, Lee S: Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis. Blood 145(12): 1321-332, Mar 2025.

Baumrin E, Cronholm P, Kearney M, Mengesha M, Cesar L, Keddem S, Schapira M, Lee S, Loren A, Gelfand J: Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 161(3): 281-90, Mar 2025.

Alvarado S, Cohen O, Lattanzio K, Haun P, Gelfand J, Loren A, Chung J, Baumrin E: Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease. Am J Dermatopathol 46(11): 755-60, Nov 2024.

Pidala J, Onstad L, Baumrin E, Carpenter P, Cutler C, Arai S, Kitko C, Chen G, Lee S: Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation. Blood Adv 8(17): 4651-657, Sep 2024.

Choe J, Shields A, Ferreira A, Gold S, Gotschall J, Kamal K, Rios A, Wang R, Baumrin E, Dommasch E, Yeung H, Lipoff J, Barbieri J: Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy. JAMA Dermatol 160(7): 741-45, Jul 2024.

Baumrin E, Shin D, Mitra N, Pidala J, Jurdi N, Lee S, Loren A, Gelfand J: Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 160(4): 393-401, Apr 2024.

Rastogi S, Kim E, Gelfand J, Loren A, Baumrin E: Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies. Transplant Cell Ther 30(3): 338, Mar 2024.

Mital R, Otto T, Savu A, Baumrin E, Cardones A, Carlesimo M, Caro G, Freites-Martinez A, Hirner J, Markova A, McLellan B, Rossi A, Sauder M, Seminario-Vidal L, Sibaud V, Owen D, Dulmage B, Chen S, Kaffenberger B: Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management. Int J Dermatol 62(8): 1020-25, Aug 2023.

Baumrin E, Baker L, Byrne M, Martin P, Flowers M, Onstad L, Jurdi N, Chen H, Beeghly-Fadiel A, Lee S, Tkaczyk E: Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. JAMA Dermatol 159(4): 393-402, Apr 2023.

back to top
Last updated: 08/19/2025
The Trustees of the University of Pennsylvania